Chargement des cours...
Prévisions
L'objectif de cours moyen des analystes est de 2,58€ (+130,36%). La médiane est de 2,58€ (+130,36%).
| Acheter |
4 |
| Conserver |
2 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
AquaBounty regains NASDAQ compliance — shares jump sharply premarket
AquaBounty reported that NASDAQ on September 15, 2025 confirmed it has again met the minimum bid price requirement of $1.00. As a result, the stock rose about 33% in premarket trading. The company had received a deficiency notice for low share prices on January 15, 2025; with the confirmation, the delisting risk is removed and AquaBounty can refocus on its operations. » Plus sur de.investing.com
AquaBounty fulfills NASDAQ listing requirements again
AquaBounty said in an SEC filing that it has regained the minimum bid price requirement for continued listing on the Nasdaq Capital Market after its share price recovered substantially from a 52-week low of $0.47 and is trading again above $1.00. The Nasdaq listing department confirmed the compliance issue is resolved. The company also announced the voluntary resignation of Angela Olsen as General Counsel, Chief Compliance Officer and Corporate Secretary effective August 22, 2025; her departure is not due to disagreements with the company. » Plus sur de.investing.com
AquaBounty Technologies: General Counsel Angela Olsen resigns
AquaBounty Technologies, Inc. said that General Counsel, Chief Compliance Officer and Corporate Secretary Angela Olsen has tendered her voluntary resignation, effective August 22, 2025. The move comes against the background of significant financial difficulties at the company, visible in InvestingPro financial metrics. At the annual meeting, all nominated directors were elected and the external auditor was ratified. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | juin 2026 | |
|---|---|---|
| Chiffre d'affaires | 0,00 | - |
| Bénéfice brut | 0,00 | - |
| Bénéfice net | −1,43 Mio | 50,06% |
| EBITDA | −703,57k | 73,00% |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 5,70 Mio€ |
Nombre d'actions | 5,15 Mio |
Plus haut/bas sur 52 semaines | 2,53€ - 0,63€ |
| Dividendes | Non |
Bêta | 1,4 |
Ratio P/E | −0,28 |
Ratio PEG | 0,00 |
Ratio P/B | 2,36 |
Ratio P/S | 0,00 |
Profil de l'entreprise
AquaBounty Technologies, Inc. ist ein Biotechnologieunternehmen, das sich auf die Steigerung der Produktivität in der kommerziellen Aquakultur in den Vereinigten Staaten und Kanada konzentriert. Das Unternehmen ist in den Bereichen Genetik, Genomik, Fischgesundheit und Ernährung tätig. Es bietet AquAdvantage Salmon an, einen biotechnologisch gezüchteten Atlantischen Lachs für den menschlichen Verzehr, und vertreibt konventionellen Atlantischen Lachs, Lachseier, Fischbrut und Nebenprodukte. Das Unternehmen war früher als Aqua Bounty Farms, Inc. bekannt und änderte im Juni 2004 seinen Namen in AquaBounty Technologies, Inc. um. AquaBounty Technologies, Inc. wurde 1991 gegründet und hat seinen Hauptsitz in Maynard, Massachusetts.
| Nom | AquaBounty Technologies |
| PDG | David A. Frank |
| Siège social | Maynard,
ma États-Unis |
| Site web | |
| Introduction en bourse | 11/01/2017 |
| Employés | 3 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NASDAQ | AQB |
Düsseldorf | W8NB.DU |
Frankfurt | W8NB.F |
München | W8NB.MU |
Découvrir des actifs
Les actionnaires de AquaBounty Technologies investissent également dans les actifs suivants
